SONU Band Review 2026: Price, Evidence, HSA/FSA

SONU is a $299 headband that hums at your sinuses. A small, company-run but properly blinded trial found it relieved allergy and non-allergy congestion better than a sham. Whether it rivals a steroid spray, as its marketing says, is a question no head-to-head study has answered.

Presented By Our Partners

In 1902, a physician named Spiess described a crude test of the nose: hum, block one nostril, and listen for the change in timbre. It is one of the oldest acoustic tests of nasal airflow on record, according to a 2002 review of acoustic rhinometry in Allergy (PMID 11990714). Exactly a century later, two researchers at the Karolinska Hospital in Stockholm measured what humming does inside the head. In 10 healthy adults, nitric oxide in nasal air rose 15-fold during humming compared with a quiet exhale, because the vibrating airflow pumped gas in and out of the sinuses. The authors closed with a suggestion: someone should study whether that better sinus ventilation has therapeutic effects (PMID 12119224).

The SONU Band is one answer to that suggestion. Made by SoundHealth, a Bay Area company, it is a soft headband with two bone conduction transducers that sit on the forehead and play tones the company says are tuned to the resonant frequencies of your own sinuses, calculated from a selfie. TIME named it one of the Best Inventions of 2025, and its product page leans on three claims: FDA cleared, drug-free, and as good as a steroid spray (SoundHealth).

The first two claims hold up. The third is where the story gets interesting, because it rests on a trial of 52 people and a comparison that was never actually run.

First look. Healthcare Discovery did not test the SONU Band hands-on. This review is built from the published studies found in a PubMed search on November 1, 2026, the FDA’s device records, SoundHealth’s own product and support pages, and named hands-on reviews. Every study below links to its PubMed record.

The short answer: The SONU Band is an FDA-authorized headband that uses personalized sound vibration to relieve nasal congestion from allergic and non-allergic rhinitis in people 12 and older. In a 52-person double-blind trial, it improved congestion scores about twice as much as a sham band over two weeks, with no adverse events. That is real evidence, but it is small, short and company-run, and no study has compared SONU directly with a steroid spray.

Best for: Teens and adults with ongoing allergy or non-allergy congestion who want to rely less on sprays and pills, and who will commit to 15 minutes twice a day.
Not for: A cold or sinus infection, which is not what it was tested for; children under 12; anyone with one-sided blockage, nosebleeds, facial swelling or fever; buyers who want the cheapest proven option.
Price (November 2026): $299 direct from SoundHealth in black or gray, with no subscription and a 30-day return window.
Regulatory status: FDA De Novo authorization DEN230045, granted December 4, 2023 (Class II), and a later 510(k) clearance, K242214, dated April 24, 2025. It is authorized and cleared, not “approved” in the FDA’s technical sense.
Evidence: Moderate for short-term congestion relief, based on one sham-controlled randomized trial; weak for the steroid spray comparison, for long-term use, and for how it works.

What Is the SONU Band?

The SONU Band is a wearable acoustic therapy headband made by SoundHealth (Sound Health Systems, Inc.) for at-home relief of moderate to severe nasal congestion caused by allergic and non-allergic rhinitis in people 12 and older. It pairs with a free iPhone or Android app, costs $299, and is used for 15-minute sessions, ideally twice a day.

The box holds the band, a USB-C cable and a quick start guide (Amazon listing). SoundHealth’s support page says a charge lasts about 75 minutes, or five sessions, and recommends charging daily (SoundHealth support). The band itself has a single power button and a USB-C port, and one hands-on reviewer found that intensity is adjusted in the app rather than on the band (Sypnotix). Forbes reported that one band supports up to four personalized user profiles, so a household can share it (Forbes).

SoundHealth launched SONU commercially in July 2024 alongside a $7 million seed round (Business Wire), announced the expanded indication for ages 12 and up in June 2025 (Business Wire), and added an Android app in July 2025 (Business Wire via Silicon UK). The app does more than run therapy sessions. SoundHealth says a feature called SONUCheck scores nasal breathing from your voice, and SONUCast forecasts your allergy symptoms from your face scan and local air quality (Business Wire). We found no published validation of either feature.

How Does the SONU Band Work?

The app scans your face with the phone camera, estimates the shape and volume of your nasal and sinus cavities, and calculates the frequencies at which those cavities should resonate. The band then plays those tones through two bone conduction transducers on the forehead for 15 minutes, which you hear as melodic tones and feel as a gentle buzz.

The physics is the same one you use when you blow across the mouth of a bottle. Every hollow space has frequencies at which it vibrates most readily, and a small push at the right frequency produces a large response. The sinuses are a set of air-filled chambers behind the forehead, cheeks and eyes, connected to the nose by narrow openings. SONU’s premise is that driving those chambers at their own resonant frequencies moves more air and tissue than a generic buzz would, which is why the frequencies are personalized rather than fixed.

SoundHealth describes three intended effects: less swelling of the nasal lining, thinner mucus, and better mucociliary clearance, the nose’s self-cleaning conveyor belt of tiny hairs (HIT Consultant). Its releases also point to the humming research and to possible effects on the nerves that control blood flow in the nasal lining (Business Wire).

Here the evidence thins. Humming reliably raises nasal nitric oxide (PMID 12119224), and a 2022 scoping review of 44 studies found that vibration and acoustic energy improved pain, sinus symptoms and imaging measures in small studies (PMID 35218159). But we found no published study that measured SONU’s effect on nasal swelling, mucus, cilia or nitric oxide in people. A 2025 review in Frontiers in Allergy lays out plausible pathways and calls for rigorously designed trials to test them (PMID 40927538). We also did not find a published study comparing the app’s sinus estimates with CT scans. The mechanism is a hypothesis; the symptom scores are the evidence.

Does the SONU Band Work? What the Research Shows

In the one sham-controlled trial, yes, modestly. Over two weeks, 52 adults using active SONU therapy improved their congestion scores about twice as much as those using a sham band, with no adverse events. A small uncontrolled study in teens found similar improvement. Every published SONU study includes SoundHealth staff among its authors.

The Pivotal Trial: 52 Adults, Two Weeks, Double-Blind

The key study, published in October 2023 in the International Forum of Allergy & Rhinology, enrolled 52 adults with allergic or non-allergic rhinitis at multiple centers. Participants were randomly assigned to active acoustic resonance therapy or a non-therapeutic sham, delivered by the headband twice daily for two weeks, and neither participants nor investigators knew who had which (PMID 37812532).

The results, from the same paper: the nasal congestion score, rated from 0 to 3, fell by 0.87 with active therapy versus 0.44 with sham (p = 0.008). The Total Nasal Symptom Score, which adds congestion, runny nose, itching and sneezing on a 0 to 12 scale, fell by 2.85 versus 1.32 (p = 0.027). Using a minimal clinically important change of 0.23 points on the congestion score, 80.8 percent of the active group responded compared with 46.2 percent of the sham group, an adjusted risk ratio of 1.95. The trial recorded no adverse events (PMID 37812532).

The 80 percent figure in SoundHealth’s marketing is real. Look at the sham arm, though: nearly half of the people wearing a band designed to do nothing therapeutic also improved by the trial’s definition. That is normal in symptom trials, and it is exactly why a sham arm matters. SONU’s honest effect is the gap between the two groups: roughly 0.4 points on the 3-point congestion scale and roughly 1.5 points on the 12-point total, over two weeks, in 52 people (PMID 37812532). The responder threshold of 0.23 points is also a low bar, so “responder” here means noticeably better, not cured.

The Pilot and the Teen Study

The trial’s authors describe an earlier pilot in which the therapy relieved congestion acutely. It was published in 2021 as a short report in the same journal (PMID 34355851), but PubMed lists no abstract for it, so we cannot report its numbers.

The teen data came later. A single-center feasibility study of acoustic vibrational therapy for pediatric rhinitis, published in May 2026 in OTO Open enrolled 31 people aged 12 to 21 with a congestion score of at least 2 out of 3. Over two weeks of treatment, the congestion score fell by 0.76 points (35.2 percent) and the total symptom score fell by 2.74 points (40.5 percent), with every other symptom improving as well (PMID 42256726). There was no sham group, so these gains cannot be separated from placebo or natural fluctuation, and the authors conclude that the therapy warrants further investigation. The paper appeared nearly a year after SoundHealth announced the expanded indication for ages 12 and up.

Real-World Use, Anatomy and CPAP

A 2025 report in the International Forum of Allergy & Rhinology analyzed people using the headband at home and found that those whose nasal cavities were deeper relative to their height, as estimated by SoundHealth’s AI, used the therapy more often. The authors suggest that ratio may mark a higher risk of congestion (PMID 41158109). It is an observational finding about usage, not a test of whether the therapy works.

For people with sleep apnea, a 2023 meeting abstract in Sleep described a prospective, non-randomized study in which adults with obstructive sleep apnea and nasal congestion used SONU for 15 minutes each night before putting on their CPAP mask for 28 days; SONU use was associated with more hours of CPAP use and fewer nasal symptoms (DOI 10.1093/sleep/zsad077.0486). A conference abstract with no control group is a signal, not proof, but it points at a real problem: a blocked nose is a common reason people abandon CPAP. If that is you, our ResMed AirSense 11 review covers the machine side of the equation.

Who Ran the Studies

SoundHealth’s founder and chief executive, Paramesh Gopi, and Vivek Mohan list SoundHealth as their affiliation on the randomized trial, the acoustic vibrational therapy study in pediatric rhinitis and the anatomy report (PMID 37812532, PMID 42256726, PMID 41158109). Peter Hwang, a Stanford rhinologist who is an author on every SONU paper above and on the 2021 pilot, was described in coverage of the 2024 launch as SoundHealth’s founder and head of research (The Supper). SoundHealth itself calls the randomized trial a SoundHealth-sponsored study (Business Wire).

Company funding does not make a result wrong. Randomization, blinding and a sham arm protect against much of the bias that sponsorship can introduce, and the trial had investigators at Harvard, UT Health Houston and community practices. What is missing is replication by a team with no stake in the product. Notably, the 2022 scoping review that Hwang co-wrote, published before the trial, concluded that study designs were too varied to say whether acoustic energy works as a primary treatment (PMID 35218159).

Featured Partner

Invest in the Infrastructure Behind Modern Medicine

As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.

Learn More →

What Other Acoustic Devices Show

SONU is not the only device built on the humming idea. SinuSonic, a handheld nasal mask that combines acoustic vibration with gentle resistance on the exhale, was tested by the Medical University of South Carolina in 40 people with chronic congestion; peak nasal inflow rose 25 liters per minute (31 percent) after two weeks, and the total symptom score fell from 7.2 to 3.5 after five weeks, with no adverse effects (PMID 32104962). A 14-person pilot found immediate improvement in congestion ratings (PMID 31695522). Neither study had a control group. Across trials of acoustic devices, the 2025 Frontiers in Allergy review reports nasal airflow gains of roughly 17 to 31 percent (PMID 40927538). The pattern is consistent, but most of it is uncontrolled, which makes SONU’s sham-controlled trial the strongest single study in the category.

Is the SONU Band as Good as a Steroid Nasal Spray?

No study has tested that. SoundHealth’s claim that SONU equals or beats the leading steroid spray comes from comparing results across separate trials, not from a head-to-head trial, and that kind of comparison cannot settle the question.

The claim is explicit. SoundHealth’s June 2025 release calls SONU the only FDA-approved device “equivalent to or better than the leading nasal steroid spray” (Business Wire). The arithmetic behind it probably looks like this. In a pooled analysis of three trials in 919 people with year-round allergies, fluticasone furoate spray beat placebo on the 12-point total nasal symptom score by 0.93 points over four weeks, and by 0.20 to 0.28 points on each individual symptom, including congestion (PMID 23676578). SONU’s gap over sham was about 1.5 points on the total score and about 0.4 points on congestion (PMID 37812532). On paper, SONU wins.

On paper is the problem. The spray analysis pooled 919 people; the SONU trial had 52, so its estimates carry far more uncertainty, and the confidence intervals for the active and sham changes in total score overlap. The spray trials ran four weeks, SONU’s two. The spray trials enrolled people with perennial allergies; SONU’s included non-allergic rhinitis too. A device you can hear and feel is also harder to disguise with a sham than a spray is with a placebo bottle. And both bodies of evidence were funded by the companies that sell the products: the fluticasone analysis was written by GlaxoSmithKline statisticians (PMID 23676578). The fair reading is that SONU’s effect falls in a range that makes it a plausible alternative or add-on, not that it has been shown to match a steroid spray.

Steroid sprays have decades of trials behind them and are sold over the counter as inexpensive generics. They work best taken every day: a 2022 meta-analysis of 8 trials in 882 people found regular use beat as-needed use, though as-needed use still clearly beat placebo (PMID 35379997). Decongestant sprays such as oxymetazoline work within minutes, and their labels limit use to three days because of rebound congestion. A 2025 review written by authors from Haleon, which sells decongestant sprays, found no evidence of rebound within a week at standard doses (PMID 40580050), while another 2025 review describes how prolonged overuse can lead to rhinitis medicamentosa, a cycle of worsening congestion and dependence (PMID 41394157). Oral phenylephrine, the decongestant in many cold pills, is a weaker option still: in November 2024 the FDA proposed removing it from over-the-counter decongestant products after concluding it does not work (FDA).

That landscape is SONU’s real opening. It has no drug, no rebound and no daily dose to track, which matters most for people who cannot or prefer not to use medication, and for people whose sprays have stopped being enough.

Is the SONU Band FDA Approved?

Strictly speaking, no: it is FDA authorized and cleared, which is the normal route for a device like this. The FDA granted De Novo request DEN230045 on December 4, 2023, creating a new Class II device type called an external mechanical stimulator for the relief of congestion (product code QZC, 21 CFR 874.6010) (FDA record via 510kdatabase.net). The FDA database also lists a traditional 510(k) clearance for Sonu, K242214, dated April 24, 2025 (FDA record via 510kdatabase.net).

The wording matters because the three terms mean different things. Approval refers to premarket approval, the pathway for the highest-risk devices. A De Novo grant covers novel low-to-moderate risk devices with no existing equivalent, based on a showing of reasonable assurance of safety and effectiveness. A 510(k) clearance means a device is substantially equivalent to one already on the market. SoundHealth’s pages use “FDA approved,” “FDA cleared” and “FDA 510(k) cleared” interchangeably (SoundHealth); all refer to the same authorizations, and “De Novo authorized and 510(k) cleared” is the accurate phrase. The device is sold over the counter for people 12 and older, and the app listing says SONU is authorized only in the United States and Singapore (app listing).

The product page also carries a “VA Approved” badge. SoundHealth markets SONU to Veterans Affairs medical centers (SoundHealth for clinicians), and Forbes reported adoption in VA clinics (Forbes). We could not confirm what “VA Approved” refers to, such as a national contract or a formulary listing, so veterans should ask their VA clinician whether it can be ordered through their facility.

What the SONU Band Gets Right

SONU did something most consumer health gadgets never do: it ran a randomized, double-blind, sham-controlled trial and published it in a specialty journal before scaling up. It also offers a genuinely drug-free option for a common, nagging problem, with an easy routine and no reported side effects so far.

A real control group. The randomized trial compared SONU against a sham band under double-blind conditions, and the difference held on both the congestion score and the total symptom score (PMID 37812532). Plenty of devices in this market cite only before-and-after surveys.

No drug, no rebound. Because nothing enters the body, there is no rebound congestion and no systemic side effect profile to manage. The trial reported no adverse events.

Low effort. A session is 15 minutes, and you can work, read or watch something while it runs. Reviewers describe it as pleasant rather than uncomfortable (Sypnotix).

A household device. Up to four personalized profiles means one band can serve a family member over 12 as well (Forbes).

A useful bridge for CPAP users. The early CPAP abstract is preliminary, but a drug-free way to open the nose before bed addresses a known reason people quit sleep apnea treatment (DOI 10.1093/sleep/zsad077.0486).

Where the SONU Band Falls Short

The evidence is one small, two-week, company-run trial, so long-term benefit and independent replication are missing. The marketing overstates both the regulatory status and the steroid spray comparison, and the routine asks for 30 minutes a day and a daily charge.

Thin evidence. Fifty-two people for two weeks is a solid start, not a settled answer (PMID 37812532). We found no published data on whether relief lasts months, whether it fades if you stop, or how SONU performs during peak pollen season compared with off season.

Company-linked research. Every SONU paper includes SoundHealth staff or its research lead. Independent replication would do more for its credibility than another award.

Marketing ahead of the data. “FDA approved” is technically inaccurate, the steroid spray claim has never been tested head to head, and “no side effects” means none were recorded in a 52-person, two-week trial, which cannot rule out uncommon ones.

Time and charging. Two daily sessions add up to 30 minutes, and a full charge covers about five sessions, so SoundHealth recommends charging every day (SoundHealth support).

Mixed hands-on reports. A TechRadar reviewer reported relief by the end of every 15-minute session (TechRadar), while a reviewer at Sypnotix, who bought one, wrote that it did not solve their congestion and kept taking their usual medications (Sypnotix). Anecdotes cut both ways, which is what the trial’s 46 percent sham response would predict.

A narrow indication. SONU was tested for rhinitis, meaning allergy and non-allergy congestion. We found no evidence that it helps a cold, a bacterial sinus infection, nasal polyps or a deviated septum.

SONU Band vs Steroid Spray vs Tivic ClearUP vs SinuSonic

SONU has the strongest controlled evidence among drug-free congestion devices, but a daily steroid spray still has far more evidence overall and costs much less. Tivic ClearUP and SinuSonic are cheaper drug-free alternatives whose studies had no control group.

Feature	SONU Band	Steroid spray (such as fluticasone)	Tivic ClearUP	SinuSonic
How it works	Personalized sound vibration from a forehead headband	Anti-inflammatory medication sprayed into the nose	Handheld microcurrent device moved along the cheeks and brow	Handheld nasal mask combining humming-style vibration with exhale resistance
Time per day	15 minutes, twice daily	Seconds, usually once daily	About 5 minutes per use in its study	A few minutes per use
Best published evidence	52-person double-blind, sham-controlled trial (PMID 37812532)	Many placebo-controlled trials, including a 919-person pooled analysis (PMID 23676578)	30-person single-arm, 4-week study (PMID 32232107)	40-person uncontrolled, 5-week study (PMID 32104962)
FDA status	De Novo DEN230045 and 510(k) K242214; over the counter, ages 12+	Over-the-counter drug	510(k) K182025 and De Novo DEN200006	Not verified for this review
Price (as reported)	$299, one-time	Low-cost generics widely available	About $149 to $170	$49.95 at launch; each device lasts up to 60 days
Main drawback	Small, company-run evidence; daily charging	A daily medication; works best with steady use	Small, company-linked studies; no control group in its published trial	Uncontrolled studies only; a replaceable device

Sources for the table: SONU trial from the International Forum of Allergy & Rhinology (PMID 37812532); fluticasone analysis from Allergy and Asthma Proceedings (PMID 23676578); ClearUP study from Bioelectronic Medicine, with a Tivic Health author (PMID 32232107); ClearUP clearances from Tivic’s IPO filing summary (Renaissance Capital) and prices from Nanalyze and WeTried; SinuSonic study (PMID 32104962) and launch price from Sleep Review.

If nasal breathing is the goal, pair any of these with a breathing practice: our guide to cyclic sighing covers the five-minute protocol tested at Stanford. The humming research behind SONU also comes up in our Sensate 2 review, where it shows why vibration on the chest is not the same thing. If congestion comes with loud snoring and daytime exhaustion, a home sleep test such as the WatchPAT One is a better first step than any gadget. Every device we track is in our healthtech wearables guide.

How Much Does the SONU Band Cost, and Is It HSA or FSA Eligible?

The SONU Band costs $299 direct from SoundHealth, in black or gray, with no subscription that we could find (SoundHealth). SoundHealth says it is FSA and HSA eligible but not covered by insurance (SoundHealth support).

SoundHealth offers a 30-day return policy (SoundHealth support), and its Amazon listing describes a 90-day limited warranty alongside the 30-day trial (Amazon listing); we could not confirm the current Amazon price. SoundHealth’s own clinician page notes that FSA and HSA eligibility can vary by plan and administrator (SoundHealth for clinicians), so check with yours before paying with pre-tax funds.

On value, SoundHealth argues the band pays for itself in 15 months compared with a $20-a-month spray (SoundHealth). That math depends on what you pay now; a cheaper generic stretches the payback period. The better way to judge it is the 30-day window. Use it twice a day, every day, and keep a simple 0 to 3 congestion log like the one in the trial. If your scores drop and you reach for the spray less, it is earning its price. If not, send it back.

Who Should Buy the SONU Band, and Who Should Skip It?

SONU suits teens and adults with ongoing allergy or non-allergy congestion who want to cut back on medication and will stick to a twice-daily routine. It is a poor fit for colds and sinus infections, for children under 12, for anyone with warning signs that need a doctor, and for budget buyers whose spray already works.

Good candidates:

People with year-round or seasonal rhinitis who want a drug-free option or an add-on to their current treatment.
People who have been told to avoid or limit decongestants, or who dislike daily steroid sprays.
CPAP users whose blocked nose makes the mask hard to tolerate, with their sleep physician’s input.
Households with more than one congested member aged 12 or older, since profiles can be shared.

Better served by something else:

Anyone with blockage on one side only, frequent nosebleeds, facial swelling or pain with fever, vision changes, or a lasting loss of smell: see a clinician. The Healthcare Discovery doctor directory lists otolaryngologists and allergists by state.
Children under 12: SONU is not indicated for them.
People who are pregnant: SoundHealth says SONU has no known systemic side effects, but we found no published study in pregnancy, so ask your obstetrician first.
Budget buyers whose generic steroid spray already controls their symptoms.
Anyone with loud snoring, gasping at night or severe daytime sleepiness: congestion may not be the main problem, and a sleep study is the right next step.

What This Means for You

A clear nose belongs to two of the Five Pillars at once, Breath and Sleep. Nasal congestion pushes people toward mouth breathing, makes CPAP harder to tolerate and turns nights restless, so a safe, drug-free way to open the airway has real value even if its effect is modest.

The SONU Band has earned more credibility than most wellness devices: a blinded, sham-controlled trial, an FDA De Novo grant and a sensible routine. It has not earned the claim that it matches a steroid spray, and its evidence still comes from a small group of people, over a short time, from researchers tied to the company. Buy it if you want to rely less on medication and will use it consistently, and judge it by your own symptom log inside the return window.

A century ago, Spiess used a hum to listen to the nose. The 2002 Karolinska study showed the hum also ventilates the sinuses. SONU turns that hum into something you wear, and the first good trial says it helps. The next trial, run by someone without a stake in the answer, will say how much.

Compiled by Healthcare Discovery from the cited PubMed studies, FDA device records, and SoundHealth’s product and support pages. Every PMID, study size and result on this page was checked against PubMed on November 1, 2026. Price, battery, warranty and feature details come from SoundHealth and named retailers and reviewers and were not independently tested. This is a first look; no Healthcare Discovery hands-on testing was done.

Frequently Asked Questions

Does the SONU Band Actually Work?

In a 52-person double-blind randomized trial, two weeks of SONU therapy reduced nasal congestion scores by 0.87 points on a 3-point scale versus 0.44 with a sham band, and 80.8 percent of users improved meaningfully versus 46.2 percent on sham (PMID 37812532). The evidence is real but small, short and company-run, and independent replication is still missing.

Is the SONU Band FDA Approved?

It is FDA authorized and cleared rather than approved. The FDA granted De Novo request DEN230045 on December 4, 2023, and lists a 510(k) clearance, K242214, dated April 24, 2025. It is sold over the counter for moderate to severe congestion from allergic and non-allergic rhinitis in people 12 and older.

Is SONU as Good as Flonase or Other Steroid Sprays?

No study has compared them directly. SoundHealth’s claim comes from comparing separate trials: a 919-person fluticasone analysis (PMID 23676578) and the 52-person SONU trial (PMID 37812532). Differences in size, length and patients make that comparison unreliable, so SONU is best seen as a plausible drug-free alternative or add-on, not a proven equal.

How Long Does SONU Take to Work, and How Often Do You Use It?

Each session lasts 15 minutes, and SoundHealth recommends two sessions a day. Hands-on reviewers report relief during a session, but the trial measured average improvement over two weeks of twice-daily use (PMID 37812532). A full charge covers about five sessions.

Is the SONU Band HSA or FSA Eligible, and Does Insurance Cover It?

SoundHealth says the SONU Band is FSA and HSA eligible but not covered by insurance. Eligibility can vary by plan, so check with your administrator. It costs $299 with a 30-day return window.

Does SONU Help With a Cold or Sinus Infection?

SONU was tested and authorized for congestion from allergic and non-allergic rhinitis, not colds or bacterial sinus infections. We found no evidence for those uses. One-sided blockage, facial swelling with fever, nosebleeds or vision changes need a clinician, not a device.

Sources

Luong AU, et al. Acoustic resonance therapy is safe and effective for the treatment of nasal congestion in rhinitis: a randomized sham-controlled trial. International Forum of Allergy & Rhinology, 2023. PMID 37812532
Khanwalkar AR, et al. Acoustic vibrational therapy for the treatment of pediatric rhinitis. OTO Open, 2026. PMID 42256726
Khanwalkar A, et al. Resonant vibration of the sinonasal cavities for the treatment of nasal congestion. International Forum of Allergy & Rhinology, 2021. PMID 34355851
Levi L, et al. The influence of nasal cavity dimensions on frequency of treatment for rhinitis symptoms. International Forum of Allergy & Rhinology, 2025. PMID 41158109
Munafo D, Gopi P, Mohan V, et al. 0486 The effect of acoustic resonance therapy on CPAP adherence (meeting abstract). Sleep, 2023. DOI 10.1093/sleep/zsad077.0486
Phillips KM, Roozdar P, Hwang PH. Applications of vibrational energy in the treatment of sinonasal disease: a scoping review. International Forum of Allergy & Rhinology, 2022. PMID 35218159
Alao JO, et al. Acoustic therapy for allergic rhinitis and chronic rhinosinusitis: modulating microbiome, immunity and well-being. Frontiers in Allergy, 2025. PMID 40927538
Weitzberg E, Lundberg JON. Humming greatly increases nasal nitric oxide. American Journal of Respiratory and Critical Care Medicine, 2002. PMID 12119224
Hilberg O. Objective measurement of nasal airway dimensions using acoustic rhinometry: methodological and clinical aspects. Allergy, 2002. PMID 11990714
Soler ZM, et al. A novel device combining acoustic vibration with oscillating expiratory pressure for the treatment of nasal congestion. International Forum of Allergy & Rhinology, 2020. PMID 32104962
Cairns A, Bogan R. The SinuSonic: reducing nasal congestion with acoustic vibration and oscillating expiratory pressure. Medical Devices: Evidence and Research, 2019. PMID 31695522
Goldsobel AB, Prabhakar N, Gurfein BT. Prospective trial examining safety and efficacy of microcurrent stimulation for the treatment of sinus pain and congestion. Bioelectronic Medicine, 2019. PMID 32232107
Wu W, et al. An integrated analysis of the efficacy of fluticasone furoate nasal spray versus placebo on the nasal symptoms of perennial allergic rhinitis. Allergy and Asthma Proceedings, 2013. PMID 23676578
Hoang MP, et al. As-needed intranasal corticosteroid spray for allergic rhinitis: a systematic review and meta-analysis. Rhinology, 2022. PMID 35379997
Hagen M, et al. Revisiting rhinitis medicamentosa: examining the evidence on topical nasal decongestants. Journal of Pharmacy Practice, 2025. PMID 40580050
Stinson RJ, Sadofsky LR. Part II, imidazolines and rhinitis medicamentosa: how can we tackle the rebound dilemma? Frontiers in Pharmacology, 2025. PMID 41394157
FDA. DEN230045, Sonu, Sound Health Systems, Inc., De Novo granted December 4, 2023. 510kdatabase.net
FDA. K242214, Sonu, 510(k) cleared April 24, 2025. 510kdatabase.net
FDA. FDA proposes ending use of oral phenylephrine as OTC monograph nasal decongestant active ingredient after extensive review, November 2024. fda.gov
SoundHealth. SONU Band product page. soundhealth.life
SoundHealth. Support and FAQ. soundhealth.life
SoundHealth. Healthcare professionals page. soundhealth.life
SoundHealth. SONU Headband landing page. soundhealth.life
Business Wire. SoundHealth receives $7 million seed-round funding and launches SONU, July 2024. Business Wire
Business Wire. SONU Band by SoundHealth receives pediatric FDA approval, June 2025. Business Wire
Business Wire via Silicon UK. SoundHealth launches Android app for its FDA-approved SONU Band, July 2025. Silicon UK
Business Wire. SoundHealth unveils SONUCast, September 2024. Business Wire
HIT Consultant. SoundHealth launches FDA-cleared AI wearable for treating nasal congestion, July 2024. HIT Consultant
The Supper. New solution for nasal congestion. The Supper
Forbes. Sonu is turning sound therapy into the next wave of wearable wellness, June 2025. Forbes
Amazon. SONU Headband for Nasal Congestion Relief listing. amazon.com
SONU app listing, regulatory jurisdiction. mwm.ai
TechRadar. I tried an AI-powered headband that uses weird sounds to unblock your nose. TechRadar
Sypnotix. SONU Band review. Sypnotix
Sleep Review. Sleep science duo launches device for nasal congestion relief. Sleep Review
Renaissance Capital. Tivic Health Systems IPO profile. Renaissance Capital
Nanalyze. Tivic Health sees huge market in consumer neuromodulation. Nanalyze
WeTried. ClearUP review. WeTried

SONU Band at a glance

Hardware price: $299
Subscription: None required
First year total: $299
Form factor: Headband (forehead, two bone conduction transducers) with iOS/Android app
FDA status: Has FDA clearance
HSA/FSA: Eligible

Measures Nasal breathing score (SONUCheck, app), Nasal congestion relief (acoustic resonance therapy)

Pricing verified November 1, 2026. Maintained in the Healthcare Discovery device database and updated automatically.

Free Daily Briefing

The Latest Longevity Science.
Delivered Every Morning.

Join researchers, physicians, and health professionals getting daily breakthroughs in AI-driven medicine, epigenetics, and longevity research.

Support the research that powers this editorial

No spam. Unsubscribe anytime. We respect your inbox.

SONU Band Review 2026: $299 Price, Drug-Free Congestion Relief, HSA/FSA Status

What Is the SONU Band?

How Does the SONU Band Work?

Does the SONU Band Work? What the Research Shows